These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3807827)

  • 1. Dietary calcium deprivation and secondary hyperparathyroidism in patients treated with chronic dialysis.
    Popovtzer MM; Michael UF; Johnson-Dial KS; Ronstadt C; Nelson D; Ogden DA
    Miner Electrolyte Metab; 1986; 12(5-6):298-302. PubMed ID: 3807827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secondary hyperparathyroidism in patients on maintenance hemodialysis.
    Hida M
    Tokai J Exp Clin Med; 1982 Nov; 7(6):665-70. PubMed ID: 7184198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The interaction of PTH and dietary phosphorus and calcium on serum calcitriol levels in the rat with experimental renal failure.
    Martin-Malo A; Rodriguez M; Martinez ME; Torres A; Felsenfeld AJ
    Nephrol Dial Transplant; 1996 Aug; 11(8):1553-8. PubMed ID: 8856210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of correlation between calcium intake and serum calcium levels in stable haemodialysis subjects.
    Byrne FN; Kinsella S; Murnaghan DJ; Kiely M; Eustace JA
    Nephron Clin Pract; 2009; 113(3):c162-8. PubMed ID: 19672114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prevalence of secondary hyperparathyroidism (SHPT) and causal factors in adult population in Reykjavík area].
    Karlsson SL; Indridason OS; Franzson L; Sigurdsson G
    Laeknabladid; 2005 Feb; 91(2):161-9. PubMed ID: 16155312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Early treatment of secondary hyperparathyroidism in moderate renal insufficiency: low-phosphorus diet versus calcium carbonate].
    Aresté N; Amor J; Cambil T; Salgueira M; Sánchez-Palencia R; Páez C; Gómez O; Palma A
    Nefrologia; 2003; 23 Suppl 2():64-8. PubMed ID: 12778857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parathyroidectomy as a therapeutic tool for targeting the recommended NKF-K/DOQI ranges for serum calcium, phosphate and parathyroid hormone in dialysis patients.
    Mazzaferro S; Pasquali M; Farcomeni A; Vestri AR; Filippini A; Romani AM; Barresi G; Pugliese F
    Nephrol Dial Transplant; 2008 Jul; 23(7):2319-23. PubMed ID: 18281320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral paricalcitol for the treatment of secondary hyperparathyroidism in patients on hemodialysis or peritoneal dialysis.
    Ross EA; Tian J; Abboud H; Hippensteel R; Melnick JZ; Pradhan RS; Williams LA; Hamm LL; Sprague SM
    Am J Nephrol; 2008; 28(1):97-106. PubMed ID: 17914251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
    Nasri H; Baradaran A; Naderi AS
    Acta Med Austriaca; 2004 Aug; 31(3):67-72. PubMed ID: 15515479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
    Nasri H; Baradaran A
    J Ayub Med Coll Abbottabad; 2004; 16(2):3-8. PubMed ID: 15455608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Low dosage intravenous calcitriol bolus therapy in chronic hemodialysis patients].
    Neyer U; Wöss E; Drexel H
    Acta Med Austriaca; 1994; 21(5):129-32. PubMed ID: 7709710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RenaGel efficacy in severe secondary hyperparathyroidism.
    Castro R; Herman A; Ferreira C; Travassos F; Nunes-Azevedo J; Oliveira M
    Nefrologia; 2002; 22(5):448-55. PubMed ID: 12497746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral calcium effectively reduces parathyroid hormone levels in hemodialysis patients: a randomized double-blind placebo-controlled study.
    Rudnicki M; Højsted J; Petersen LJ; Sørensen HA; Hyldstrup L; Transbøl I
    Nephron; 1993; 65(3):369-74. PubMed ID: 8289986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of predialytic intact parathyroid hormone on secondary hyperparathyroidism in chronic maintenance haemodialysis patients.
    Etoh S; Murata T; Hasegawa Y; Miyahara Y; Ishimura A; Abe Y; Noda R; Ogahara S; Kaneoka H; Saito T
    Nephrology (Carlton); 2004 Jun; 9(3):161-6. PubMed ID: 15189177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secondary hyperparathyroidism in severe chronic renal failure is corrected by very-low dietary phosphate intake and calcium carbonate supplementation.
    Barsotti G; Cupisti A; Morelli E; Meola M; Cozza V; Barsotti M; Giovannetti S
    Nephron; 1998; 79(2):137-41. PubMed ID: 9647491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum trypsin-like immunoreactivity and secondary hyperparathyroidism in renal failure.
    Antonucci F; Vezzadini P; Adorati M; Bonora G; Messa P; Montanaro D; Mioni G
    Scand J Gastroenterol Suppl; 1980; 62():53-7. PubMed ID: 6161411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary phosphate restriction in dialysis patients: a new approach for the treatment of hyperphosphataemia.
    Guida B; Piccoli A; Trio R; Laccetti R; Nastasi A; Paglione A; Memoli A; Memoli B
    Nutr Metab Cardiovasc Dis; 2011 Nov; 21(11):879-84. PubMed ID: 20609572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does long term haemofiltration provoke secondary hyperparathyroidism?
    Schneider H; Streicher E; Schmidt-Gayk H; Bosnjakovic S
    Proc Eur Dial Transplant Assoc; 1978; 15():532-9. PubMed ID: 740684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphate excretion in chronic renal failure: evidence for a mechanism other than circulating parathyroid hormone.
    Fotino S
    Clin Nephrol; 1977 Dec; 8(6):499-503. PubMed ID: 598054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.